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Dear Editor, 
 
Resveratrol (3,5,4′-trihydroxy-trans-stilbene) is a stilbenoid and polyphenolic compound. It 
is found naturally, especially in plants sources such as peanuts, grapes, and some berries (Diaz-
Gerevini et al., 2016). In plants, resveratrol is produced via the phenylpropanoid pathway. It is 
derived from p-coumaric acid, which is an intermediate formed during lignin production. The 
4-coumarate:coenzyme A (CoA) ligase converts p-coumaric acid to coumaroyl-CoA, along 
with three units of malonyl-CoA, which are then condensed to form resveratrol by resveratrol 
synthase or stilbene synthase (Deng et al., 2016; Zhang et al., 2015; Zheng et al., 2015; Kim et 
al., 2013). 
Resveratrol is the most widely studied plant-derived polyphenol. Several studies have been 
reported on its numerous biological and pharmacological effects. These include neuroprotective 
(Su et al., 2016), antiobesity (Chang et al., 2016), antiviral (Abba et al., 2015), hepatoprotective 
(Faghihzadeh et al., 2015), anti-inflammatory (Liu et al., 2015), cardioprotective (Raj et al., 
2015), anticancer (Kumar et al., 2015), anti-atherogenic (Riccioni et al., 2015), antidiabetic 
(Szkudelski and Szkudelska, 2015), and antioxidant (Yun et al., 2014) activities. Resveratrol 
shows a wide range of biological activities and health benefits in humans, which makes it a 
beneficial substance for use in the pharmaceutical, food, and cosmetic industries. We present a 
review of the most recent studies on the benefits of resveratrol, especially its biological and 
pharmacological activities (Table 1). 
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Table 1: The biological and pharmacological properties of resveratrol reported by recent studies 
Key findings Reference 
Resveratrol helped to improve blood supply to the femoral head in a rabbit model 
of osteonecrosis, which might help to protect the vascular endothelium and reduce 
thrombosis through an anti-inflammatory effect. 
Zhai et al., 
2016 
Dietary intake or therapeutic administration of resveratrol affects the skeletal mus-
cle phenotype in a muscle-specific manner. Therefore, resveratrol supplementa-
tion could be a vital approach for promoting the generation of fatigue-resistant my-
osin heavy chain (type I) isoform, specifically if its expression is suppressed as a 
result of a long-term high-fat or sugar diet. 
Hyatt et al., 
2016 
The findings of the study emphasize new mechanistic insights that dihydro-
resveratrol can protect against oxidative damage in the pancreas. In addition, the 
findings support the potential of dihydro-resveratrol for the remedy of acute pan-
creatitis, especially in patients who are not responsive to trans-resveratrol because 
they lack the necessary microbiota strains. 
Tsang et al., 
2016 
Resveratrol chemosensitized cancer cells to doxorubicin by protecting against cell 
proliferation and breast cancer. Additionally, co-treatment with resveratrol and dox-
orubicin induced apoptosis through the suppression of chronic inflammation and 
autophagy. 
Rai et al., 2016 
Resveratrol influences the differentiation of preadipocytes by hindering insulin sig-
naling, mitochondrial biogenesis, lipogenesis, and lipid storage, which contribute to 
weight loss in both humans and animals. 
Li et al., 2016a 
Resveratrol has beneficial effects on redox balance in bovine mammary epithelial 
cells. Therefore, it could be a vital therapeutic agent against oxidative insults in 
lactating animals. 
Jin et al., 2016 
Resveratrol has the ability to ameliorate sporadic hypoxia-induced anxiety. Fur-
thermore, it causes spatial learning deficits through its effects on hippocampal oxi-
dative pathways, which may directly involve decreasing the expression of the 
p47Phox subunit of nicotinamide adenine dinucleotide phosphate (NADPH) oxi-
dase. In addition, resveratrol has a potential therapeutic role in obstructive sleep 
apnea, which should be investigated in further studies. 
Abdel-Wahab 
et al., 2016 
Resveratrol acts as a blocker of signal transduction, as well as an activator of the 
transcription of STAT3 and STAT5. Moreover, through these mechanisms, 
resveratrol may exert a potential growth inhibitory effect on renal carcinoma cells. 
Kim et al., 2016 
Combined therapy using resveratrol and an enriched environment evidently im-
proved the neuroprotective effect of resveratrol, compared to monotherapy using 
either treatment. Therefore, this combination therapy could be researched for 
treating ischemic brain injury. 
Su et al., 2016 
It was reported that resveratrol showed a potent immune-enhancing activity in im-
munosuppressed mice. The authors indicated that the possible mechanism under-
lying the observed action was the activation of nuclear factor-kappa B. 
Lai et al., 2016 
Resveratrol influenced the behavior of rats undergoing cocaine withdrawal. In ad-
dition, it was indicated that oxidative stress, inflammation, apoptosis, and silent in-
formation regulator 1 signaling pathways in the hippocampus, prefrontal cortex, or 
in both might be involved in mediating the observed effects of resveratrol. 
Hu et al., 2016 
Resveratrol modified dendritic morphology in the prefrontal cortex, hippocampus, 
and dentate gyrus, which explained the potential therapeutic effect of resveratrol in 
both aging and Alzheimer’s disease (AD).  
Monserrat Her-
nández-Her-
nández et al., 
2016 
Resveratrol advanced the vasoprotective effect of captopril on aortic remodeling 
and fibrosis during renovascular hypertension. This effect was mediated through 
the synergetic antioxidant and nitric oxide generation actions of resveratrol. 
Natalin et al., 
2016 
Resveratrol showed an anti-obesity effect through the induction of cytotoxicity 
when it was used at a high dosage. However, at lower concentrations, it influenced 
preadipocyte differentiation and lipolysis in mature adipocytes. 
Chang et al., 
2016 
Low-intensity exercise training combined with supplementation with resveratrol 
and piperine increased the mitochondrial capacity of the forearm skeletal muscle.  
Polley et al., 
2016 
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Key findings Reference 
Co-treatment with diclofenac and resveratrol may represent a novel approach to 
reducing the dosage and gastrointestinal side effects of diclofenac. 
Bedada et al., 
2016 
Metabolic and cardiac functions improved independence of sex through dietary 
supplementation with resveratrol in Sprague-Dawley rats. This study showed the 
therapeutic role of resveratrol in the male and female rat offspring that experienced 
prenatal hypoxia. 
Shah et al., 
2016 
Resveratrol had beneficial effects in the liver by attenuating oxidative stress and 
downregulating the expression of receptor for advanced glycation end products. 
Khazaei et al., 
2016 
Resveratrol played a positive role in suppressing pancreatic cancer progression in-
duced by hypoxia-driven reactive oxygen species (ROS) by inhibiting the hedge-
hog signaling pathway. This result suggests that resveratrol may be a potential 
candidate for the chemoprevention of cancer. 
Li et al., 2016b 
It was demonstrated that resveratrol serves as a clinically and economically feasi-
ble therapeutic agent for reducing the global burden of iron-overload cardiomyopa-
thy at its early and chronic stages. 
Das et al., 2015
Resveratrol induced the apoptosis of human leukemic K562 cells via the mitochon-
drial signaling pathway. This finding necessitates in vivo studies on the potential 
use of resveratrol as an anticancer agent. 
Wang et al., 
2015 
It was demonstrated that resveratrol is effective against ischemia-induced apopto-
sis in the rat hippocampus through its neuroprotective and antioxidant effects. 
Meng et al., 
2015 
Resveratrol inhibited glucose uptake and had a significant antineoplastic effect in a 
preclinical mouse model of ovarian cancer. In addition, treatment with resveratrol 
suppressed tumor regrowth after therapy with cisplatin, suggesting that resveratrol 
has the potential to prolong disease-free survival. 
Tan et al., 2016 
Resveratrol exerted both anti-apoptotic and anti-catabolic effects on compression 
injury in the skeletal muscle of rats. However, these effects required the action of 
silent mating type information of 2 homolog 1. 
Sin et al., 2015 
The authors demonstrated the potential therapeutic use of resveratrol to prevent 
the development of proliferative vitreoretinopathy by targeting retinal pigment epi-
thelial cells during their epithelial to mesenchymal transition. 
Ishikawa et al., 
2015 
It was shown that resveratrol has a considerable antiepileptic effect. In addition, it 
has a neuroprotective effect and counters epileptic depression. The findings indi-
cated that resveratrol has the potential to be a new antiepileptic drug; therefore, 
more studies are needed to further elucidate its therapeutic potential. 
Lu and Wang, 
2015 
Resveratrol alleviates hepatic steatosis and inflammation in choline-deficiency-in-
duced non-alcoholic steatohepatitis (NASH) through autophagy. Therefore, 
resveratrol may be useful for inhibiting accumulation of lipids and the inflammatory 
processes associated with NASH. 
Ji et al., 2015 
It was reported that habitual dietary intake of resveratrol is associated with a low 
risk of developing frailty syndrome in community-dwelling elderly people. This ef-
fect was observed during the first 3 years of follow-up but not after longer follow-up 
periods. 
Rabassa et al., 
2015 
Intake of fructose for a long period may have different metabolic and vascular ef-
fects on male and female rats; however, these effects were observed to be modi-
fied by resveratrol. 
Pektaş et al., 
2015 
It was documented that resveratrol is a compound for the potential treatment of 
thrombovascular diseases through its antiplatelet effect. This effect was observed 
to occur via the inhibition of ROS production induced by NADPH oxidase and the 
subsequent oxidative inactivation of SHP-2.  
Jang et al., 
2015 
This recent study provided direct electrophysiological evidence of the inhibitory ef-
fect of resveratrol on pyramidal neurons. This effect was mediated, at least in part, 
by the reduction of evoked neural activity. 
Meftahi et al., 
2015 
It was demonstrated that attenuation of inflammatory responses might be involved 
in the mechanisms underlying the cardioprotective effect of resveratrol. The find-
ings showed the response of resveratrol to myocardial ischemia/reperfusion injury. 
Dong et al., 
2015 
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Key findings Reference 
Resveratrol improved the hepatic and peripheral insulin resistance induced by free 
fatty acids. Therefore, it may help to mitigate the health consequences of obesity. 
Pereira et al., 
2015 
The genotoxic potential of resveratrol might be attributed to its sulfate- and glucu-
ronide-phase II metabolites through the inhibition of topoisomerase II activity. In 
addition, resveratrol-3-sulfate might serve as a pool for the parent compound by 
deconjugation at its target site. 
Schroeter et al., 
2015 
Diseases involving pathological neovascularization could be managed based on 
the therapeutic value of resveratrol.  Lee et al., 2015 
Resveratrol modified kidney histology and leptin expression level in diabetic rats 
through its antioxidant and antidiabetic effects. Therefore, resveratrol might be 
useful in the prevention of kidney damage caused by long-term hyperglycemia. 
Yaylali et al., 
2015 
Resveratrol performed more favorably than famotidine did because resveratrol 
prevents long-term methotrexate toxicity but does not inhibit gastric acid secretion. 
Arslan et al., 
2015 
Resveratrol exhibited a therapeutic potential against myeloproliferative neoplasms, 
which is evident of its aberrant activation of the janus kinase 2 pathway. 
Trung et al., 
2015 
Resveratrol emerged as a potential agent for the treatment of conditions associ-
ated with androgen excess, such as polycystic ovarian syndrome. However, fur-
ther studies are required to evaluate the efficacy of resveratrol for the treatment of 
gynecological conditions. 
Ortega and 
Duleba, 2015 
Resveratrol was recognized as a safe compound since no significant toxic effects 
were observed after several concentrations were tested. In addition, it was consid-
ered as an effective anti-atherogenic agent. 
Riccioni et al., 
2015 
Resveratrol was found to be a potential agent for reducing human rhinovirus repli-
cation and virus-induced cytokine/chemokine production. 
Mastromarino 
et al., 2015 
It was considered that NADPH oxidase might be a potential target in AD treatment 
and that resveratrol may be used as a natural product with a therapeutic potential 
against AD. 
Yao et al., 2015
From histopathological and immunohistochemical analyses that were performed, it 
was observed that resveratrol ameliorates cisplatin-induced oxidative injury in the 
rabbit kidney. 
Cigremis et al., 
2015 
Resveratrol might be considered a potential natural product for development as a 
medicine or dietary supplement for the prevention and treatment osteoporosis. 
Zhao et al., 
2015 
Resveratrol ameliorated spatial learning and memory deficit in a rat model of sub-
clinical hypothyroidism. The mechanism involved in this effect might modify the hy-
peractive hypothalamic-pituitary-thyroid axis and upregulate the hippocampal hy-
poexpression of synaptotagmin 1 and brain-derived neurotrophic factor. 
Ge et al., 2015 
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